Your browser doesn't support javascript.
loading
Safety and effectiveness of disease-modifying therapies after switching from natalizumab.
Zeineddine, Maya; Al-Roughani, Raed; Farouk Ahmed, Samar; Khoury, Samia; El-Ayoubi, Nabil; Al-Mahdawi, Akram; Al-Khabouri, Jaber; Al-Asmi, Abdullah; Chentouf, Amina; Inshasi, Jihad; Gouider, Riadh; Mrabet, Saloua; Shalaby, Nevin; Massouh, Joelle; Mohamed Ramzy Hasan Mohamed, Farah; Al-Hajje, Amal; Salameh, Pascale; Dimassi, Hani; Boumediene, Farid; Yamout, Bassem.
Affiliation
  • Zeineddine M; Inserm U1094, IRD U270, Univ. Limoges, CHU Limoges, EpiMaCT-Epidemiology of chronic diseases in tropical zone, Institute of Epidemiology and Tropical Neurology, Omega Health, Limoges, France.
  • Al-Roughani R; School of Pharmacy, Lebanese American University, Byblos, Lebanon.
  • Farouk Ahmed S; Al-Amiri Hospital, Kuwait City, Kuwait.
  • Khoury S; Ibn Sina Hospital, Kuwait City, Kuwait.
  • El-Ayoubi N; American University of Beirut Medical Center, Nehme and Therese Tohme Multiple Sclerosis Center, Beirut, Lebanon.
  • Al-Mahdawi A; American University of Beirut Medical Center, Nehme and Therese Tohme Multiple Sclerosis Center, Beirut, Lebanon.
  • Al-Khabouri J; Baghdad Medical City Teaching Hospital, Baghdad, Iraq.
  • Al-Asmi A; Department of Neurology, The Royal Hospital, Muscat, Oman.
  • Chentouf A; Neurology Unit, Department of Medicine, College of Medicine and Health Sciences and Sultan Qaboos University Hospital, Sultan Qaboos University, Muscat, Oman.
  • Inshasi J; Neurology Department, University Hospital Center, Oran, Algeria.
  • Gouider R; MS Department, Rashid Hospital and Dubai Medical College, Dubai Health Authority, Dubai, United Arab Emirates.
  • Mrabet S; Department of Neurology, LR18SP03, Clinical Investigation Center "Neurosciences and Mental Health," Razi University Hospital-Manouba, Tunis, Tunisia.
  • Shalaby N; Department of Neurology, LR18SP03, Clinical Investigation Center "Neurosciences and Mental Health," Razi University Hospital-Manouba, Tunis, Tunisia.
  • Massouh J; Neurology Department, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt.
  • Mohamed Ramzy Hasan Mohamed F; Neurology Institute and MS Center, Harley Street Medical Center, Abu Dhabi, United Arab Emirates.
  • Al-Hajje A; Neurology Institute and MS Center, Harley Street Medical Center, Abu Dhabi, United Arab Emirates.
  • Salameh P; Faculty of Pharmacy, Lebanese University, Beirut, Lebanon.
  • Dimassi H; National Institute of Public Health, Clinical Epidemiology and Toxicology (INSPECT-LB), Beirut, Lebanon.
  • Boumediene F; Faculty of Pharmacy, Lebanese University, Beirut, Lebanon.
  • Yamout B; National Institute of Public Health, Clinical Epidemiology and Toxicology (INSPECT-LB), Beirut, Lebanon.
Mult Scler ; 30(8): 1026-1035, 2024 Jul.
Article in En | MEDLINE | ID: mdl-39054846
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukoencephalopathy, Progressive Multifocal / JC Virus / Multiple Sclerosis, Relapsing-Remitting / Natalizumab / Immunologic Factors Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Mult Scler Journal subject: NEUROLOGIA Year: 2024 Document type: Article Affiliation country: Francia Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukoencephalopathy, Progressive Multifocal / JC Virus / Multiple Sclerosis, Relapsing-Remitting / Natalizumab / Immunologic Factors Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Mult Scler Journal subject: NEUROLOGIA Year: 2024 Document type: Article Affiliation country: Francia Country of publication: Reino Unido